"Kidney Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancers of the KIDNEY.
Descriptor ID |
D007680
|
MeSH Number(s) |
C04.588.945.947.535 C12.758.820.750 C12.777.419.473 C13.351.937.820.535 C13.351.968.419.473
|
Concept/Terms |
Kidney Neoplasms- Kidney Neoplasms
- Kidney Neoplasm
- Neoplasm, Kidney
- Renal Neoplasms
- Neoplasm, Renal
- Neoplasms, Renal
- Renal Neoplasm
- Neoplasms, Kidney
Cancer of Kidney- Cancer of Kidney
- Kidney Cancers
- Renal Cancer
- Cancer, Renal
- Cancers, Renal
- Renal Cancers
- Cancer of the Kidney
- Kidney Cancer
- Cancer, Kidney
- Cancers, Kidney
|
Below are MeSH descriptors whose meaning is more general than "Kidney Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Kidney Neoplasms".
This graph shows the total number of publications written about "Kidney Neoplasms" by people in this website by year, and whether "Kidney Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 2 | 1 | 3 |
1995 | 3 | 0 | 3 |
1996 | 1 | 1 | 2 |
1997 | 3 | 0 | 3 |
1998 | 10 | 0 | 10 |
1999 | 5 | 0 | 5 |
2000 | 13 | 0 | 13 |
2001 | 8 | 2 | 10 |
2002 | 9 | 2 | 11 |
2003 | 8 | 2 | 10 |
2004 | 21 | 0 | 21 |
2005 | 14 | 4 | 18 |
2006 | 22 | 5 | 27 |
2007 | 20 | 4 | 24 |
2008 | 22 | 0 | 22 |
2009 | 27 | 1 | 28 |
2010 | 22 | 4 | 26 |
2011 | 9 | 2 | 11 |
2012 | 13 | 1 | 14 |
2013 | 19 | 3 | 22 |
2014 | 18 | 3 | 21 |
2015 | 16 | 0 | 16 |
2016 | 29 | 0 | 29 |
2017 | 10 | 2 | 12 |
2018 | 12 | 2 | 14 |
2019 | 13 | 0 | 13 |
2020 | 13 | 2 | 15 |
2021 | 18 | 2 | 20 |
2022 | 11 | 0 | 11 |
2023 | 4 | 0 | 4 |
2024 | 4 | 0 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Kidney Neoplasms" by people in Profiles.
-
Cystic Features in Renal Epithelial Neoplasms and Their Increasing Clinical and Pathologic Significance. Adv Anat Pathol. 2024 May 01; 31(3):157-168.
-
A phase 1b open-label study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of py314 in combination with pembrolizumab in patients with advanced renal cell carcinoma. Invest New Drugs. 2024 Apr; 42(2):179-184.
-
Actual encounters of the kidney kind: Exploring 48 cases of renal collision tumors through the lens of literature. Hum Pathol. 2024 Mar; 145:26-33.
-
NCCN GuidelinesĀ® Insights: Kidney Cancer, Version 2.2024. J Natl Compr Canc Netw. 2024 02; 22(1):4-16.
-
Twelve-Month Follow-up of the Immune Response After COVID-19 Vaccination in Patients with Genitourinary Cancers: A Prospective Cohort Analysis. Oncologist. 2023 09 07; 28(9):e748-e755.
-
An International Survey of Genitourinary and Renal Pathologists Regarding Evaluation of the Non-Neoplastic Parenchyma in Kidney Cancer Specimens. Int J Surg Pathol. 2024 Apr; 32(2):273-278.
-
Cystic MED15::TFE3 translocation renal cell carcinoma: histologic mimicker of multilocular cystic renal neoplasm of low malignant potential with review of the literature. Hum Pathol. 2023 06; 136:25-33.
-
Top 10 Clear Cell Head and Neck Lesions to Contemplate. Head Neck Pathol. 2023 Mar; 17(1):33-52.
-
TSC/MTOR mutated renal cell carcinoma with leiomyomatous stroma is a distinct entity: a comprehensive study of 12 cases. Hum Pathol. 2023 04; 134:124-133.
-
In vivo characterization of glutamine metabolism identifies therapeutic targets in clear cell renal cell carcinoma. Sci Adv. 2022 12 16; 8(50):eabp8293.